CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Taiho Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 20, 2024Anticancer Drug Containing Alpha, Alpha, Alphatrifluorothymidine And Thymidine Phosphorylase Inhibitor2
Mar 8, 2023Antitumor Agent And Antitumor Effect Enhancer2
Oct 13, 2021Stabilized Crystal Of Tipiracil Hydrochloride, And Crystallization Method For Same1
May 20, 2020Oral Pharmaceutical Composition1
May 16, 2018Oral Pharmaceutical Composition1

Top competitors of Taiho Pharmaceutical

List of top competitors of Taiho Pharmaceutical based on patent oppositions.